We are live on ! Find out more
PRLD icon

Prelude Therapeutics
PRLD

60 hedge funds and large institutions have $1.41B invested in Prelude Therapeutics in 2021 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 30 increasing their positions, 8 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

275% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 8

113% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 8

18% more funds holding

Funds holding: 51 → 60 (+9)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

9.44% less ownership

Funds ownership: 79.29% → 69.85% (-9.4%)

43% less capital invested

Capital invested by funds: $2.47B → $1.41B (-$1.06B)

Holders
60
Holders Change
+9
Holders Change %
+17.65%
% of All Funds
1.05%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
17
Increased
30
Reduced
8
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$135M
2
State Street
State Street
Massachusetts
+$48.5M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$13.8M
4
Federated Hermes
Federated Hermes
Pennsylvania
+$12.3M
5
UBS AM
UBS AM
Illinois
+$8.42M

Top Sellers

Rank Fund Capital Flow
1
O
OrbiMed
New York
-$369M
2
HA
HHLR Advisors
Cayman Islands
-$8.19M
3
SCM
Suvretta Capital Management
New York
-$7.95M
4
CCM
CAAS Capital Management
New York
-$3.58M
5
Squarepoint
Squarepoint
New York
-$1.48M
Name Holding Trade Value Shares
Change 		Change in
Stake
IA
51
IFP Advisors
Florida
$52K +$79.2K +1,194 New
Pacer Advisors
52
Pacer Advisors
Pennsylvania
$49K +$74.7K +1,126 New
Legal & General Group
53
Legal & General Group
United Kingdom
$45K +$2.92K +44 +4%
Wells Fargo
54
Wells Fargo
California
$44K -$251K -3,791 -79%
AIP
55
Ameritas Investment Partners
Nebraska
$33K – – –
SOW
56
State of Wyoming
Wyoming
$17K +$26.5K +399 New
Osaic Holdings
57
Osaic Holdings
Arizona
$15K +$22.6K +340 New
Bank of Montreal
58
Bank of Montreal
Ontario, Canada
$11K -$75.2K -1,134 -79%
JCM
59
Jacobi Capital Management
Pennsylvania
$11K – – –
AIG
60
American International Group
New York
$250 +$29.1K +438 +8%
SCM
61
Suvretta Capital Management
New York
– -$7.95M -111,065 Closed
CCM
62
CAAS Capital Management
New York
– -$3.58M -50,000 Closed
Squarepoint
63
Squarepoint
New York
– -$1.48M -20,726 Closed
PCS
64
Personal CFO Solutions
New Jersey
– -$322K -4,500 Closed
VOYA Investment Management
65
VOYA Investment Management
Georgia
– -$262K -3,665 Closed
OWP
66
Old Well Partners
North Carolina
– -$247K -3,450 Closed
AC
67
Athanor Capital
New York
– -$241K -3,374 Closed
US Bancorp
68
US Bancorp
Minnesota
– -$1K -18 Closed
1 2
3

PRLD Hedge Fund Activity: Q1 2021 in Review

60 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Prelude Therapeutics (PRLD) for Q1 2021, worth a combined $1.41B — down 43% from $2.47B a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new PRLD positions and 8 closed out — a net gain of 9 holders — while 30 added to existing stakes and 8 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $135M. The largest seller was OrbiMed, cutting an estimated $369M.

  • 60 institutional investors held Prelude Therapeutics (PRLD) as of Q1 2021, up from 51 in Q4 2020.
  • Funds reported $1.41B of Prelude Therapeutics stock for Q1 2021, down 43% quarter-over-quarter.
  • 17 funds opened new Prelude Therapeutics positions in Q1 2021 and 8 closed out, a net change of +9 holders.
  • The largest Prelude Therapeutics buyer in Q1 2021 was Fidelity Investments, an estimated $135M added.
  • The largest Prelude Therapeutics seller in Q1 2021 was OrbiMed, an estimated $369M sold.

Based on aggregated 13F filings for Q1 2021.